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Abstract
Background: The apoptosis-inducing serine protease granzyme B (GrB) is an important factor contributing to lysis of target
cells by cytotoxic lymphocytes. Expression of enzymatically active GrB in recombinant form is a prerequisite for functional
analysis and application of GrB for therapeutic purposes.
Methods and Findings: We investigated the influence of bacterial maltose-binding protein (MBP) fused to GrB via a
synthetic furin recognition motif on the expression of the MBP fusion protein also containing an N-terminal a-factor signal
peptide in the yeast Pichia pastoris. MBP markedly enhanced the amount of GrB secreted into culture supernatant, which
was not the case when GrB was fused to GST. MBP-GrB fusion protein was cleaved during secretion by an endogenous furin-
like proteolytic activity in vivo, liberating enzymatically active GrB without the need of subsequent in vitro processing.
Similar results were obtained upon expression of a recombinant fragment of the ErbB2/HER2 receptor protein or GST as
MBP fusions.
Conclusions: Our results demonstrate that combination of MBP as a solubility enhancer with specific in vivo cleavage
augments secretion of processed and functionally active proteins from yeast. This strategy may be generally applicable to
improve folding and increase yields of recombinant proteins.
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Introduction
Many mammalian proteins can be expressed at high levels in the
prokaryotic host E. coli, but frequently accumulate in a misfolded and
biologically inactive form in inclusion bodies [1]. Protein solubility
can either be enhanced by modifying the production process, or by
protein engineering. Most efforts have been directed to chemical
denaturation of purified inclusion body proteins followed by refolding
procedures.However,thisstrategy needstobe adapted toa particular
protein species, and the yields of soluble protein can vary
considerably. Attempts to prevent inclusion body formation and
directly increase the solubility of recombinant proteins include
expression of the protein of interest fused to a heterologous protein
domain as a solubilizing agent [2]. Protein domains employed in this
manner comprise glutathione-S-transferase (GST) from Schistosoma
japonicum [3], thioredoxin [4], ubiquitin [5], protein A [6], DsbA [7],
domain 1 of the translation initiation factor IF2 [8], and the maltose-
binding protein (MBP) of E. coli [9,10].
MBP is part of a large class of proteins that aid in the uptake of
small molecules [11]. While it naturally resides in the periplasm,
MBP can also be expressed at high yields in the cytoplasm. For
different proteins increased solubility, enhanced stability and
markedly improved yields have been reported after fusion to MBP
[12,13,14,15]. This has been explained by the ability of MBP to
act as a chaperone in the context of a fusion protein, and promote
the proper folding of the fusion partner [10,16,17]. Here we
investigated the potential of MBP to improve as part of a fusion
protein the expression of human granzyme B (GrB) as a secreted
recombinant protein in the methylotrophic yeast Pichia pastoris.
The serine protease GrB is normally released by cytotoxic
lymphocytes. It enters target cells together with the pore-forming
protein perforin and induces apoptosis by activating caspase-
dependent and caspase-independent programmed cell death
pathways [18,19]. The availability of GrB in recombinant form is
an important prerequisite for functional analysis, and is essential for
application of GrB as a therapeutic effector protein [20,21]. P.
pastoris has previously been employed to generate recombinant GrB
from different mammalian species [22,23,24]. This yeast represents
a widely established eukaryotic expression system for proteins that
are secreted to the extracellular space [25]. Fusion of the yeast
mating type a-factor signal peptide to the protein of interest thereby
directs it to the secretory pathway, where it becomes glycosylated
before release into the culture supernatant. GrB derivatives have
also been expressed as GST fusion proteins in E. coli [21]. Thereby
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introduced between GrB and GST domains was required during
purification to separate the proteins and yield active enzyme.
To circumvent the need for in vitro processing, we included a
synthetic furin recognition motif between the protein domains of
MBP-GrB fusion proteins and investigated potential in vivo
cleavage by endogenous furin-like proteases from yeast. Analysis
of P. pastoris culture supernatants revealed that fusion to MBP
markedly enhanced the amount of soluble GrB, while this was not
the case when GrB was fused to GST. GrB was liberated from
MBP by specific in vivo cleavage during secretion, allowing direct
isolation of the enzyme in processed form. Similar results were
obtained upon expression of a recombinant fragment of the
ErbB2/HER2 receptor protein or GST as MBP fusions, indicating
that this approach can generally be applied to enhance secretion
and yields of functionally active recombinant proteins.
Results and Discussion
Expression of granzyme B fusion proteins in the yeast
Pichia pastoris
To investigate the effects of MBP and GST on the expression
and secretion of human GrB in P. pastoris, pPIC9-based yeast
expression constructs were generated. These encode under the
control of the methanol-inducible AOX1 promoter fusion proteins
consisting of an N-terminal a-factor signal peptide followed by
MBP or GST, and a C-terminal domain encompassing residues
21–247 of human GrB which represents the mature form of the
serine protease (Fig. 1A). To facilitate possible in vivo processing of
the fusion proteins, a synthetic furin recognition motif Arg-Ala-
Arg-Tyr-Lys-Arg-Ser (furS) was included between the fusion
partners and GrB. The furS motif was previously identified as
an optimal furin recognition site effectively cleaved by the enzyme
in in vitro assays employing synthetic peptide substrates [26]. For
comparison the similar construct pPIC9-GrB encoding unfused
mature human GrB was included [24].
After induction with methanol, culture supernatants from
individual yeast cell clones were analyzed for the presence of GrB
(Fig. 1B). Only 3 out of 5 pPIC9-GrB clones expressed GrB at
levels above the detection limit, whereas processed mature GrB
was detected in the supernatants of all pPIC9-GST-furS-GrB or
pPIC9-MBP-furS-GrB clones. Thereby expression levels of GrB
derived from MBP-furS-GrB appeared more homogenous
among different clones than those of GrB, or GrB derived from
GST-furS-GrB. For subsequent analysis a representative pPIC9-
M B P - f u r S - G r By e a s tc l o n ea n dthe pPIC9-GrB and pPIC9-
Figure 1. Expression of GrB in the yeast Pichia pastoris. (A) Constructs for expression of human granzyme B, and MBP-GrB and GST-GrB fusion
proteins. AOX1, methanol-inducible alcohol oxidase I promoter; SP, a-factor signal peptide; furS, furin recognition motif; M, Myc tag; H, polyhistidine
tag. (B) Culture supernatants of yeast clones carrying pPIC9-GrB, pPIC9-GST-furS-GrB, or pPIC9-MBP-furS-GrB were collected after induction with
methanol for 3 days, and expression of GrB was analyzed by immunoblotting with GrB-specific antibody. Each lane represents an individual clone.
Clones marked with an asterisk were used in subsequent experiments. (C) For comparison, culture supernatants of clones carrying the different
expression constructs were analyzed together in a single immunoblot experiment as indicated. Supernatant of a yeast clone carrying empty pPIC9
served as a control.
doi:10.1371/journal.pone.0014404.g001
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selected.
Secretion of GrB into the culture medium
Supernatants of expression cultures induced with methanol for 3
days were analyzed by immunoblotting (Fig. 1C). No bands
representing full-length GST-furS-GrB or MBP-furS-GrB proteins
(calculated molecular weights in non-glycosylated form 56 and
71 kDa) were detected with GrB-specific antibody. For each clone
only a single protein band appeared that migrated at an apparent
molecular weight of 40 kDa expected for glycosylated GrB [24].
This suggests that both fusion proteins were completely processed,
presumably within the furin cleavage site which can be recognized
by the endogenous furin-like yeast protease kexin [27].
The highest amount of processed GrB was found in supernatant
of the pPIC9-MBP-furS-GrB cell clone, with a more moderate
GrB level obtained from the clone transformed with the pPIC9-
GrB control construct. The lowest amount of processed GrB was
detected in supernatant of the pPIC9-GST-furS-GrB cell clone
(Fig. 1C). To investigate the kinetics of GrB expression, samples of
culture supernatants were collected from methanol-induced
cultures of pPIC9-GrB, pPIC9-GST-furS-GrB, or pPIC9-MBP-
furS-GrB clones from day 1 to 4 after induction. Immunoblot
analysis revealed an increasing accumulation of processed GrB
over time, with the highest amounts again produced by P. pastoris
carrying pPIC9-MBP-furS-GrB (Fig. 2A, upper panel). We found
a more than 20 times higher level of processed GrB upon
expression of MBP-furS-GrB in supernatant collected on day 2
when compared to unfused GrB. While there was a stronger
relative increase in GrB levels in the supernatants of yeast carrying
pPIC9-GrB during the following days, the GrB amount in
supernatant of pPIC9-MBP-furS-GrB cells was still more than 7
times higher after induction for 4 days (Fig. 2A, lower panel).
Expression of GST-furS-GrB fusion protein resulted in only low
amounts of processed GrB in culture supernatants during the
entire course of the experiment.
Next we investigated whether the secretion of increased levels of
processed protein was dependent on the protein of interest fused to
MBP-furS, using a soluble fragment of the extracellular domain of
the human ErbB2/HER2 receptor protein (ErbB2222) as a model
protein unrelated to GrB. As in the case of GrB, fusion to MBP-
furS markedly enhanced the levels of the processed ErbB2222
protein fragment in culture supernatants during 4 days of
induction (Fig. 2B), indicating that the MBP-furS domain
functions as a general enhancer of the expression of secreted
proteins in P. pastoris.
Growth kinetics and GrB mRNA levels
During the 4 day induction P. pastoris carrying pPIC9-MBP-
furS-GrB, pPIC9-GST-furS-GrB, pPIC9-GrB, or empty pPIC9
vector showed comparable growth rates (Fig. 3A). This demon-
strates that the increased GrB levels produced by yeast cells
expressing MBP-furS-GrB was not due to higher cell density or
enhanced proliferation. Likewise, no differences in the growth
kinetics of P. pastoris carrying pPIC9-ErbB2222 and pPIC9-MBP-
furS-ErbB2222 were observed (data not shown).
Next we analyzed the levels of GrB and GrB fusion mRNA in
yeast cells to investigate potential differences in transcription as a
factor contributing to differential GrB protein expression. After
induction with methanol for one day, quantitative real-time PCR
revealed highest mRNA expression for GST-furS-GrB, with MBP-
furS-GrB and GrB mRNA levels reaching 91% and 73% of that
(Fig. 3B). These relatively small differences in mRNA expression
did not reflect the observed differences in protein expression,
where GST-furS-GrB resulted in the lowest levels of processed
GrB. Hence, the markedly increased amount of processed GrB
upon expression of MBP-furS-GrB was not due to enhanced
transcription of the fusion construct. To estimate the potential
effect of different codon usage within the heterologous MBP and
GST domains on expression in P. pastoris, we calculated the codon
adaptation index (CAI) for both genes. A CAI value of 1 indicates
a codon choice identical to that of the host cell, while a lower CAI
value indicates a bias towards less favorable codon usage [28,29].
The calculated CAI value of 0.64 for the MBP fragment is lower
than the CAI value of 0.75 for the GST fragment, making it highly
unlikely that differences in codon usage account for the increased
amount of GrB upon expression of MBP-furS-GrB when
compared to GST-furS-GrB.
Processing of GST and MBP fusion proteins
To investigate the fate of GST and MBP domains after
expression of the fusion proteins, we examined culture superna-
tants by immunoblot analysis with GST- and MBP-specific
antibodies. Thereby no unprocessed GST-furS-GrB (Fig. 4A) or
MBP-furS-GrB (Fig. 4B) proteins were detected, confirming the
results with GrB-specific antibody shown above. However, we
observed an increase over time of soluble GST and MBP, that
reflected the previously observed levels of processed GrB (see
Fig. 2A for comparison). The apparent molecular weights of the
single bands detected correspond well with the calculated
molecular weights of the MBP (40.6 kDa) and GST (25.6 kDa)
moieties. This indicates complete processing of the fusion proteins
by cleavage within the furS recognition site in the secretory
pathway, resulting in secretion of processed GrB and both fusion
partners GST and MBP.
Proteins that are secreted by the exocytosis pathway translocate
into the membrane or lumen of the endoplasmic reticulum (ER),
and are then transported to the Golgi apparatus for sorting to
cellular destinations. Misfolded proteins are retained in the ER,
and in some cases are retranslocated from the ER and subjected to
ER-associated degradation by the ubiquitin-proteasome system
[30]. To investigate potential intracellular retention of the GrB
fusion proteins, yeast cell lysates were prepared and analyzed with
GrB-specific antibody (Fig. 4C). For unfused GrB included for
comparison we detected two bands in the intracellular fraction
migrating at approximately 44 and 53 kDa, apparently corre-
sponding to processed glycosylated GrB and glycosylated GrB still
containing the signal peptide. In contrast, only marginal amounts
of unprocessed GST-furS-GrB and MBP-furS-GrB fusion proteins
were found, together with two additional smaller bands likely
representing MBP-furS-GrB degradation products. These data
show that a large proportion of unfused GrB was retained in an
intracellular compartment likely representing the ER, while GST
and MBP domains both promoted secretion of GrB. However,
only MBP was able to enhance the overall level of GrB.
Influence of the furin recognition motif on GrB cleavage
and activity
GrB is naturally expressed as a pre-pro-enzyme, that requires
stepwise removal of the signal peptide and an N-terminal
activation dipeptide to yield active protein [31]. Hence, for
expression of recombinant GrB in P. pastoris we previously fused
the sequence of mature GrB directly to the a-factor signal peptide
in pPIC9-GrB, allowing secretion of fully processed and active
enzyme into the culture supernatant [24]. In contrast to the
minimal furin recognition motif Arg-X-X-Arg which is cleaved
after the C-terminal arginine residue, the optimized furS cleavage
site contains an additional C-terminal serine residue which is
MBP-GrB Fusion Proteins
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at the N-terminus of the cleavage product after processing
(Fig. 5A). To enable production of GrB with an N-terminus
identical to that of the natural protein, we generated a modified
pPIC9-MBP-fur-GrB construct which carries a furin recognition
motif (fur) lacking the C-terminal serine of furS.
After induction with methanol we detected significant levels of
unprocessed full-length MBP-fur-GrB in supernatants of pPIC9-
Figure 2. Analysis of GrB secreted into the culture medium. (A) Supernatants of yeast cultures harboring pPIC9-GrB, pPIC9-GST-furS-GrB, or
pPIC9-MBP-furS-GrB were collected at the indicated time points after induction with methanol, and analyzed by immunoblotting with GrB-specific
antibody. Band intensities were quantified by determining mean gray values (MGV) relative to the highest value obtained. (B) Expression of an ErbB2
protein fragment. Yeast cells carrying pPIC9-ErbB2222 or pPIC9-MBP-furS-ErbB2222 were induced with methanol, and ErbB2 protein in culture
supernatants was analyzed by immunoblotting with ErbB2-specific antibody.
doi:10.1371/journal.pone.0014404.g002
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to processed GrB (Fig. 5B). This is in contrast to the findings after
expression of MBP-furS-GrB, and indicates that furS represents a
more optimal recognition site than fur also for furin-like proteases
in yeast. To enrich the processed GrB fragment for subsequent
analysis, MBP-fur-GrB containing culture supernatant was filtered
through membranes with a 100 kDa molecular weight cut-off,
yielding a filtrate with a high proportion of in vivo processed GrB
and a retentate enriched for unprocessed MBP-fur-GrB (Fig. 5C).
Catalytic GrB activity in these samples was then analyzed in a
peptide cleavage assay using the synthetic GrB substrate Ac-
IETD-pNA [24]. As expected, protein from yeast cells expressing
MBP-fur-GrB readily cleaved the GrB-specific substrate with
kinetics similar to those of a purified recombinant GrB derivative
included for comparison, demonstrating the presence of enzymat-
ically active GrB (Fig. 5D). Thereby samples enriched for
unprocessed MBP-fur-GrB showed lower enzymatic activity than
samples containing a larger proportion of processed GrB,
indicating that processing is required to yield the active form. In
contrast, no GrB activity was detected in supernatant of MBP-
furS-GrB expressing cells despite complete in vivo processing and
liberation of the GrB domain. This strongly suggests that after
cleavage of MBP-furS-GrB the C-terminal serine of the furS motif
was retained at the N-terminus of GrB, accounting for the lack of
enzymatic activity [24].
Expression, processing and enzymatic activity of MBP-
GST fusion proteins
To investigate the influence of MBP on the expression and
catalytic activity of an enzyme unrelated to GrB, we fused GST C-
terminally to the MBP-fur or MBP-furS domains. Similar to the
corresponding GrB fusions, the resulting MBP-fur-GST and
MBP-furS-GST proteins were highly expressed in P. pastoris, and
readily secreted into the culture supernatant (Fig. 6A). This was in
marked contrast to the poor expression of the GST-furS-GrB
fusion protein carrying the GST domain at the N-terminus and
lacking MBP (see Fig. 1 for comparison), confirming that the
differential expression of GST and MBP, if not fused to each other,
is not due to differences in codon usage. Like in the case of MBP-
GrB fusion proteins, MBP-fur-GST was only partially processed
by in vivo cleavage, whereas almost quantitative processing was
observed for MBP-furS-GST, liberating MBP and GST domains
(Fig. 6A).
Enzymatic GST activity in yeast culture supernatants was
analyzed by measuring conjugation of glutathione to a synthetic
substrate. Thereby very similar activities were found for MBP-fur-
GST and MBP-furS-GST preparations irrespective of the level of
cleavage within their fur or furS sites. These results demonstrate
that unprocessed MBP-fur-GST fusion protein, and GST
generated by in vivo processing of MBP-fur-GST or MBP-furS-
GST are enzymatically active to a similar degree. Accordingly, in
contrast to GrB, in the case of GST the N-terminal serine residue
left upon cleavage of furS does not affect functionality of the
enzyme.
Conclusions
Expression of recombinant proteins in the yeast P. pastoris
represents an attractive alternative to prokaryotic expression
systems [25]. Proteins can be efficiently secreted into the culture
supernatant, which aids proper folding and allows posttranslation-
al modification such as glycosylation [24,32,33,34]. Nevertheless,
protein expression levels comparable to those of bacteria can often
not be achieved. Here we demonstrated that expression of human
GrB in P. pastoris was markedly enhanced upon fusion to bacterial
MBP as a solubilizing agent, while this was not the case after fusion
to GST. Unlike unfused GrB, which was retained to a large extent
in the intracellular compartment suggesting incorrect folding, GrB
linked to MBP was efficiently secreted. Similar results were
Figure 3. Growth kinetics of yeast clones and GrB mRNA expression. (A) Cultures of P. pastoris carrying pPIC9-GrB, pPIC9-GST-furS-GrB,
pPIC9-MBP-furS-GrB, or empty pPIC9 vector were induced with methanol. Samples were taken every 24 h, and OD600 was determined as a measure
for cell density. (B) Quantification of GrB mRNA levels. RNA was isolated from yeast cells carrying pPIC9-GrB, pPIC9-GST-furS-GrB, pPIC9-MBP-furS-GrB,
or empty pPIC9 vector after induction with methanol for one day. cDNA was synthesized and analyzed by quantitative real-time PCR including
GAPDH for normalization. Means of duplicate samples are shown. Error bars indicate SD.
doi:10.1371/journal.pone.0014404.g003
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receptor protein or GST as MBP-furS fusions. This indicates that
also in yeast the MBP domain acts like a chaperone and promotes
proper folding of the fusion partner [10,16,17]. As in the case of
GrB, fusion to a solubilizing protein domain may interfere with the
biological activity of the protein of interest, requiring separation of
the protein domains after expression. This is usually achieved by in
vitro processing with the help of an exogenously added protease that
cleaves a site introduced between the fusion partners.
To circumvent the necessity of such extensive in vitro
manipulation, we separated the MBP domain from GrB by a
furin recognition site to allow cleavage of the fusion protein in vivo.
Indeed, inclusion of the optimized furS motif resulted in
quantitative processing of MBP fusion proteins in the secretory
pathway, demonstrating that this site is efficiently recognized by a
furin-like yeast protease such as kexin [27]. Comparative analysis
of GrB enzymatic activity as a sensitive readout for correct
processing of the protein’s N-terminus indicated that cleavage of
Figure 4. Secretion of GST and MBP into the culture medium. The presence of GST and MBP in yeast culture supernatants after induction for
the indicated time periods was analyzed by immunoblotting with GST-specific (A) or MBP-specific antibodies (B). (C) Intracellular accumulation of GrB
and GrB fusion proteins was investigated by analysis of cell lysates with GrB-specific antibody. The positions of the different GrB proteins are
indicated by arrows. Samples analyzed were from the same cultures examined for secretion of GrB as shown in Fig. 2A.
doi:10.1371/journal.pone.0014404.g004
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positions. The terminal serine of furS is thereby left at the N-
terminus of processed GrB, rendering the enzyme inactive. In the
case of GrB a more basic furin recognition site must therefore be
employed to generate active enzyme with its natural N-terminus.
Nevertheless, also for MBP-fur-GrB the general expression-
enhancing effect of the MBP fusion partner was retained. Albeit
less complete than in the case of furS, in vivo cleavage of MBP-fur-
GrB was sufficiently efficient to yield overall levels of processed
GrB comparable to those generated by expression of MBP-furS-
GrB.
Recently, Li and colleagues independently reported enhanced
secretion of proteins of interest from P. pastoris after fusion to MBP
[35]. In their study processing between MBP and cargo protein
was found irrespective of the presence of a Factor Xa or an
enterokinase cleavage site within the linker. This was attributed to
Figure 5. Processing of MBP-GrB fusion proteins. (A) Variants of the furin recognition motif either containing (furS) or lacking (fur) an additional
C-terminal serine residue. (B) Culture supernatants of yeast clones carrying pPIC9-MBP-fur-GrB were collected after induction with methanol for 3
days, and expression and processing of the GrB fusion protein was analyzed by immunoblotting with GrB-specific antibody. (C) Samples enriched for
processed (100 kDa filtrate) or unprocessed MBP-fur-GrB protein (100 kDa retentate) were prepared by filtration of culture supernatant of a
representative MBP-fur-GrB clone through Amicon filters with 100 kDa membranes, and analyzed by immunoblotting with GrB-specific antibody.
Initial MBP-fur-GrB containing supernatant and supernatant from an MBP-furS-GrB clone were included for comparison. Supernatant of yeast cells
carrying empty pPIC9 served as a control. The lower apparent molecular weight of processed GrB in (C) when compared to (B) is most likely due to a
lower degree of glycosylation (calculated molecular weight for processed GrB in non-glycosylated form: 28.4 kDa). (D) Enzymatic activity of GrB
proteins from culture supernatants and kinetics of substrate cleavage were analyzed in a colorimetric peptide cleavage assay. The MBP-fur-GrB or
MBP-furS-GrB containing supernatants, and the MBP-fur-GrB samples enriched for processed (100 kDa filtrate) or unprocessed protein (100 kDa
retentate) analyzed in (C) were tested as indicated. A purified recombinant GrB derivative (GrB) was included as a positive control. Supernatant of
yeast cells carrying empty pPIC9 displayed no GrB activity (data not shown). Means of triplicate samples are shown. Error bars indicate SEM.
doi:10.1371/journal.pone.0014404.g005
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structure in MBP by an unknown P. pastoris protease, followed by
cleavage within the linker region or the cargo protein in a quasi
random fashion [35]. In contrast, in our case the efficiency of in
vivo cleavage of MBP-GrB and MBP-GST fusion proteins was
strictly dependent on the type of cleavage site fur or furS, which
only differ in one amino acid residue. Furthermore, the high
enzymatic activity observed for GrB generated upon fur cleavage
and the complete lack of enzymatic activity of GrB generated
upon processing of the furS site indicate that cleavage of the MBP
fusion proteins did not occur randomly but at the predicted
positions.
While the serine residue left after cleavage of the more efficient
furS site prevented GrB activity, it did not interfere with the
functionality of GST, which like many other enzymes does not
require exact N-terminal trimming to yield the enzymatic activity
of the wildtype protein. Our results indicate that this novel
combination of a solubilizing protein domain fused to the protein
of interest via a cleavage site for in vivo processing can be applied as
a general strategy to improve the yields of functionally active
proteins. A similar approach may also be followed for mammalian
cells, where furin is present in the secretory pathway, and even
prokaryotic expression systems, where bacterial subtilisins share
the substrate specificity of furin [36].
Materials and Methods
Construction of yeast expression plasmids
DNA fragments encoding MBP and GST were generated by
PCR using plasmids pMALc-NN-EGFP (MBP) [16] or pGEX-4T-
1 (GST) (GE Healthcare, Freiburg, Germany) as templates and
oligonucleotide primers that introduce 59 NdeI and 39 XbaI
restriction sites. cDNA fragments that encode mature human
granzyme B (GrB; amino acid residues 21–247) preceded by
sequences encoding the furin recognition motifs Arg-Ala-Arg-Tyr-
Lys-Arg-Ser (furS) or Arg-Ala-Arg-Tyr-Lys-Arg (fur) were gener-
ated by PCR using plasmid pPIC9-GrB as a template [24] and
oligonucleotide primers that introduce 59 XbaI and 39 XhoI
restriction sites. The PCR products were assembled stepwise as
NdeI/XbaI and XbaI/XhoI fragments in the pBluescript KS
+
derivative pBMH that contains a modified multiple cloning site
and sequences encoding Myc (M) and polyhistidine (H) tags [32].
From the resulting plasmids DNA fragments encoding MBP-furS-
GrB, MBP-fur-GrB, and GST-furS-GrB fusions that also harbor
Figure 6. Processing and enzymatic activity of MBP-GST fusion proteins. (A) Culture supernatants of representative yeast clones carrying
pPIC9-MBP-fur-GST or pPIC9-MBP-furS-GST were collected after induction with methanol for 3 days, and expression and processing of the MBP-GST
fusion proteins was analyzed by immunoblotting with GST-specific (left panel) or MBP-specific antibody (right panel). Supernatant of yeast cells
carrying empty pPIC9 served as a control. (B) Enzymatic activity of MBP-GST fusion proteins and kinetics of conjugation of glutathione to synthetic
CDNB substrate was analyzed in a colorimetric assay. The MBP-fur-GST or MBP-furS-GST containing supernatants analyzed in (A) were tested as
indicated. Commercially available recombinant GST was included as a positive control. Supernatant of yeast cells carrying empty pPIC9 served as
negative control. Means of triplicate samples are shown. Error bars indicate SEM.
doi:10.1371/journal.pone.0014404.g006
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with AvrII and NotI, and inserted into the respective restriction sites
of plasmid pPIC9 (Invitrogen, Darmstadt, Germany), resulting in
the yeast expression vectors pPIC9-MBP-furS-GrB, pPIC9-MBP-
fur-GrB, and pPIC9-GST-furS-GrB (Fig. 1A). In a similar fashion
the yeast expression vectors pPIC9-ErbB2222 and pPIC9-MBP-
furS-ErbB2222 for expression of an N-terminal fragment of the
human ErbB2 protein (amino acid residues 1-222, ErbB2222) and
an MBP-furS-ErbB2222 fusion were assembled using an ErbB2222
cDNA fragment derived from plasmid pSW5-ErbB2222 [37]. The
expression vectors pPIC9-MBP-fur-GST and pPIC9-MBP-furS-
GST for expression of MBP-fur-GST and MBP-furS-GST fusions
were derived by exchanging the fur-GrB fragment in pPIC9-MBP-
fur-GrB with fur-GST and furS-GST PCR fragments generated
with plasmid pGEX-4T-1 as a template.
Expression of recombinant proteins in the yeast Pichia
pastoris
P. pastoris GS115 cells (Invitrogen) were transformed with pPIC9
derivatives by electroporation, and positive clones were selected
according to the manufacturer’s recommendations. Yeast cells
carrying plasmid pPIC9-GrB [24] for expression of unmodified
GrB served as control. Single colonies were grown in 10 ml
buffered glycerol complex medium (pH 8) for 2 days at 28uC. For
induction of protein expression, cultures were diluted to an OD600
of 6 in 25 ml of buffered methanol complex medium (pH 8)
containing 2% methanol, and incubated for another 3 to 4 days at
28uC with addition of methanol every 24 h. Growth of yeast
cultures was monitored by measuring OD600 every 24 h, and
samples for subsequent analysis were collected at daily intervals.
Yeast cells and culture supernatants from harvested samples were
separated by centrifugation. For detection of recombinant
proteins, culture supernatants (secreted fraction) and yeast pellets
resuspended in PBS (intracellular fraction) were subjected to SDS-
PAGE and immunoblot analysis with GrB-specific 2C5 (Santa
Cruz), or ErbB2-specific FRP5 [38] monoclonal antibody,
followed by HRP-conjugated secondary antibody and chemilumi-
nescent detection with the ECL kit (GE Healthcare). Bands were
quantified by densitometry using ImageJ 1.32j software [39] to
determine mean gray values, calculated relative to the highest
values obtained which were set to 1. MBP and GST fusion
proteins were also analyzed by immunoblotting with MBP-specific
monoclonal antibody MBP-17 (Abcam, Cambridge, UK), or
polyclonal GST-specific antibody (GE Healthcare) followed by
HRP-conjugated secondary antibody and chemiluminescent
detection.
Isolation of yeast RNA and quantitative real-time PCR
Yeast expression cultures were induced for one day with 2%
methanol and adjusted to an OD600 of 8. Cell pellets from 1 ml
samples of the cultures were collected by centrifugation, and
resuspended in 100 ml of buffer containing 1 M sorbitol, 0.1 M
EDTA pH 7.4, 0.1% mercaptoethanol, and 50 units lyticase
(Sigma-Aldrich, Deisenhofen, Germany). Spheroblasts were al-
lowed to form by incubation for 30 min at 30uC with moderate
agitation, and then collected by centrifugation for 5 min at 3006g.
Total RNA was isolated from spheroblasts using the RNeasy Mini
Kit (Qiagen, Hilden, Germany) following the manufacturer’s
recommendations, and cDNA was synthesized from 1 to 5 mgo f
RNA following a standardized protocol as described [40].
Duplicate TaqMan PCR were performed on an Abi PRISM
7700 sequence detection system (Applied Biosystems, Weiterstadt,
Germany) with standard conditions (50uC for 2 min, 95uC for
10 min, 45 cycles at 95uC for 15 sec, 60uC for 1 min) using
Platinum RTS qPCR-Super-Mix-UDG with Rox (Invitrogen)
according to the manufacturer’s recommendations. For amplifi-
cation of the GrB fragment, 2.5 ml of template were used in 25 ml
reactions containing oligonucleotide primers 59-TGGAGGC-
CCTCTTGTGTGTAA-39 and 59-GCATGCCATTGTTTCG-
TCC-39, and the GrB-specific probe 59-AAGGTGGCCCAGGG-
CATTGTCTC-39 labeled with FAM
TM and TAMRA
TM at 59
and 39 ends, respectively. A yeast GAPDH fragment was amplified
for normalization. All primers and probes were used at a final
concentration of 200 nM. Absolute copy numbers of GrB and
GAPDH mRNA were determined by simultaneously analyzing
standard titrations of GrB and GAPDH plasmids.
Analysis of codon usage
The codon adaptation index [28,29] for the MBP and GST
gene fragments was calculated as a measure for the potential
influence of different codon usage on the expression of MBP and
GST fusion proteins in P. pastoris using a free online tool accessible
at www.genscript.com/cgi-bin/tools/rare_codon_analysis (Gen-
Script, Piscataway, NJ).
Granzyme B activity assay
Enzymatic activity of recombinant GrB was analyzed using the
synthetic GrB peptide substrate Ac-IETD-pNA (Acetyl-Ile-Glu-
Thr-Asp-p-Nitroanilide) (Alexis, Gru ¨nberg, Germany). Cleavage
reactions were prepared in triplicates in 96 well plates in a total
volume of 100 ml per well, containing 200 mM Ac-IETD-pNA
(from a 20 mM stock solution in DMSO) in reaction buffer
(10 mM HEPES pH 7.4, 140 mM NaCl, 2.5 mM CaCl2), and
20 ml of yeast culture supernatants collected after induction of
MBP-fur-GrB or MBP-furS-GrB expression for 3 days. Likewise
GrB activity was determined in MBP-fur-GrB samples containing
equivalent protein amounts but enriched for either unprocessed
(retentate) or processed MBP-fur-GrB protein (filtrate) by filtration
of culture supernatants through Amicon Ultra centrifugal filters
with 100 kDa membranes (Millipore, Schwalbach, Germany). A
highly purified recombinant GrB derivative [20] was included as a
positive control. Samples were incubated for 1 to 6 h at 37uC, and
cleavage of the GrB substrate was quantified by measuring the
absorbance at 405 nm and 490 nm with a microplate reader
(Molecular Devices, Ismaning, Germany). Peptide substrate
incubated in reaction buffer without recombinant proteins served
as blank. Culture supernatant from a yeast clone transformed with
empty pPIC9 vector served as negative control.
Glutathione-S-transferase activity assay
Enzymatic activity of MBP-fur-GST and MBP-furS-GST
proteins was analyzed using a GST assay kit (Sigma-Aldrich)
following the manufacturer’s recommendations. Yeast culture
supernatants were collected after induction of protein expression
for 3 days, 106concentrated using Amicon Ultra centrifugal filters
with 10 kDa membranes (Millipore), and dialyzed against PBS.
Reactions were prepared in triplicates in 96 well plates in a total
volume of 200 ml per well, containing 5 ml of concentrated culture
supernatant, 2 mM reduced L-glutathione, and 1 mM CDNB (1-
chloro-2,4-dinitrobenzene) substrate. Samples were incubated for
1 to 7 min at 25uC, and GST activity was quantified by measuring
the absorbance at 340 nm with a microplate reader. Buffered
substrate solution without recombinant proteins served as blank.
Enzymatically active GST provided with the kit was included as a
positive control. Concentrated culture supernatant from a yeast
clone transformed with empty pPIC9 vector served as negative
control.
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